Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Revenue: 2022-2024

Historic Revenue for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $2.6 million.

  • Orchestra BioMed Holdings' Revenue fell 12.77% to $861,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 6.46%. This contributed to the annual value of $2.6 million for FY2024, which is 4.42% down from last year.
  • As of FY2024, Orchestra BioMed Holdings' Revenue stood at $2.6 million, which was down 4.42% from $2.8 million recorded in FY2023.
  • Orchestra BioMed Holdings' 5-year Revenue high stood at $3.5 million for FY2022, and its period low was $2.6 million during FY2024.
  • Over the past 3 years, Orchestra BioMed Holdings' median Revenue value was $2.8 million (recorded in 2023), while the average stood at $3.0 million.
  • Data for Orchestra BioMed Holdings' Revenue shows a maximum YoY decreased of 21.88% (in 2023) over the last 5 years.
  • Orchestra BioMed Holdings' Revenue (Yearly) stood at $3.5 million in 2022, then declined by 21.88% to $2.8 million in 2023, then fell by 4.42% to $2.6 million in 2024.